These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 39244947)
1. Novel ABL1 mutation in a Moroccan CML patient with Imatinib resistance. El Bouchikhi I; Azami Idrissi H; Lazraq A; El Makhzen B; Ahakoud M; Berrady R; Ouldim K; Bouguenouch L; El-Azami-El-Idrissi M Cancer Genet; 2024 Nov; 288-289():40-42. PubMed ID: 39244947 [TBL] [Abstract][Full Text] [Related]
2. Occurrence of Existing BCR-ABL Baseline Mutations and Associated Haplotype (NmR) Among CML Patients with Diverse IM Response: A Hospital-based Study from North-East India. Hazarika G; Kalita MJ; Das PP; Kalita S; Dutta K; Lahkar L; Rajkonwar A; Idris MG; Khamo V; Kusre G; Medhi S Biochem Genet; 2024 Dec; 62(6):4804-4816. PubMed ID: 38363412 [TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study. Seman ZA; Ahid F; Kamaluddin NR; Sahid ENM; Esa E; Said SSM; Azman N; Mat WKDW; Abdullah J; Ali NA; Khalid MKNM; Yusoff YM BMC Res Notes; 2024 Apr; 17(1):111. PubMed ID: 38643202 [TBL] [Abstract][Full Text] [Related]
4. Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha. Ferrari-Amorotti G; Keeshan K; Zattoni M; Guerzoni C; Iotti G; Cattelani S; Donato NJ; Calabretta B Blood; 2006 Aug; 108(4):1353-62. PubMed ID: 16670262 [TBL] [Abstract][Full Text] [Related]
5. Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial. Short NJ; Nguyen D; Jabbour E; Senapati J; Zeng Z; Issa GC; Abbas H; Nasnas C; Qiao W; Huang X; Borthakur G; Chien K; Haddad FG; Pemmaraju N; Karrar OS; Nguyen D; Konopleva M; Kantarjian H; Ravandi F Lancet Haematol; 2024 Nov; 11(11):e839-e849. PubMed ID: 39303729 [TBL] [Abstract][Full Text] [Related]
6. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
7. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice. Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242 [TBL] [Abstract][Full Text] [Related]
8. BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph Peter B; Eisenwort G; Sadovnik I; Bauer K; Willmann M; Rülicke T; Berger D; Stefanzl G; Greiner G; Hoermann G; Keller A; Wolf D; Čulen M; Winter GE; Hoffmann T; Schiefer AI; Sperr WR; Zuber J; Mayer J; Valent P Am J Hematol; 2022 Sep; 97(9):1215-1225. PubMed ID: 35794848 [TBL] [Abstract][Full Text] [Related]
9. Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia. Karabay AZ; Ozkan T; Karadag Gurel A; Koc A; Hekmatshoar Y; Sunguroglu A; Aktan F; Buyukbingöl Z Naunyn Schmiedebergs Arch Pharmacol; 2024 Dec; 397(12):9701-9721. PubMed ID: 38916832 [TBL] [Abstract][Full Text] [Related]
10. The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy. Decroos A; Meddour S; Demoy M; Piccirilli N; Rousselot P; Nicolini FE; Ragot S; Gombert JM; Herbelin A; Barbarin A; Cayssials E Front Immunol; 2024; 15():1473139. PubMed ID: 39620210 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
12. Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips. Manes TJ; DeGenova DT; Taylor BC; Patel JN JBJS Essent Surg Tech; 2024; 14(4):. PubMed ID: 39650795 [TBL] [Abstract][Full Text] [Related]
13. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
14. Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study. Bucelli C; Capodanno I; Miggiano MC; Cavazzini F; Crescenzi SL; Russo S; Carmosino I; Annunziata M; Sorà F; Bonifacio M; Luciano L; Caocci G; Loglisci G; Elena C; Lunghi F; Mullai R; Attolico I; Binotto G; Crisà E; Sportoletti P; Di Veroli A; Scortechini AR; Leporace AP; Maggi A; Crugnola M; Stagno F; Sancetta R; Murgano P; Rapezzi D; Luzi D; Vincelli DI; Galimberti S; Bocchia M; Fava C; Malato A; Abruzzese E; Saglio G; Specchia G; Breccia M; Iurlo A; Tiribelli M; Latagliata R Eur J Haematol; 2025 Jan; 114(1):37-44. PubMed ID: 39263855 [TBL] [Abstract][Full Text] [Related]
15. [Treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study]. Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592 [No Abstract] [Full Text] [Related]
16. Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis. Glenton C; Paulsen E; Agarwal S; Gopinathan U; Johansen M; Kyaddondo D; Munabi-Babigumira S; Nabukenya J; Nakityo I; Namaganda R; Namitala J; Neumark T; Nsangi A; Pakenham-Walsh NM; Rashidian A; Royston G; Sewankambo N; Tamrat T; Lewin S Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015705. PubMed ID: 39189465 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Effects of Inecalcitol With Imatinib and Dasatinib on Chronic Myeloid Leukemia Cell Lines. Angel S; Cowles E; Costa J; Ani RA; Venkatachalam KV Anticancer Res; 2024 Dec; 44(12):5193-5197. PubMed ID: 39626944 [TBL] [Abstract][Full Text] [Related]
18. Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets. Mihaylova B; Wu R; Zhou J; Williams C; Schlackow I; Emberson J; Reith C; Keech A; Robson J; Parnell R; Armitage J; Gray A; Simes J; Baigent C Health Technol Assess; 2024 Dec; 28(79):1-134. PubMed ID: 39644281 [TBL] [Abstract][Full Text] [Related]
19. Exploring Inhibition Mechanisms in Wildtype and T315I BCR-ABL1: An In Silico Approach Integrating Virtual Screening, MD Simulations, and MM-GBSA Analysis. Balta O; Yilmaz E; Tatar Yilmaz G J Comput Chem; 2025 Jan; 46(1):e27545. PubMed ID: 39636243 [TBL] [Abstract][Full Text] [Related]